Company Overview and News

 
BRIEF-Goldquest Says Injunction Against Co In Dominican Republic Has No Effect On Activities

2018-04-17 reuters
* GOLDQUEST MINING -INJUNCTION IS LIMITED TO EXPLOITATION PERMIT APPLICATION FOR ROMERO CONCESSION AND DOES NOT RELATE TO CO’S EXPLORATION LICENSES Source text for Eikon: Further company coverage:
Upvote Downvote

 
GoldQuest: Injunction Against the Company in the Dominican Republic Has No Effect on Activities

2018-04-17 globenewswire
VANCOUVER, British Columbia, April 16, 2018 (GLOBE NEWSWIRE) -- GoldQuest Mining Corp. (TSXV:GQC) (FRANKFURT:M1W) (BERLIN:M1W) ("GoldQuest" or the "Company") reports that it has received the written decision of the Penal Chamber of the First Instance Court of the Judicial District of San Juan de la Maguana (the “Court”) in response to a Constitutional Injunction “Remedy” filed by a local Dominican group against GoldQuest Dominicana SRL, the Company’s wholly owned subsidiary.
Upvote Downvote

 
GoldQuest Announces Injunction Against its Activities in the Dominican Republic

2018-03-28 globenewswire
VANCOUVER, British Columbia, March 27, 2018 (GLOBE NEWSWIRE) -- GoldQuest Mining Corp. (TSXV:GQC) (FRANKFURT:M1W) (BERLIN:M1W) ("GoldQuest" or the "Company") reports that it has been advised that the Penal Chamber of the First Instance Court of the Judicial District of San Juan de la Maguana (the “Court”) has reached a decision (the “Decision”) in response to a Constitutional Injunction Remedy filed by a group of individuals in the Dominican Republic against the Company’s wholly owned subsidiary, GoldQuest Dominicana SRL.
Upvote Downvote

 
GoldQuest: Drilling at Cachimbo returns 148 m grading 0.8 g/t gold including 5.05 m grading 8.4 g/t gold

2018-01-30 marketwired
VANCOUVER, BC--(Marketwired - January 30, 2018) - GoldQuest Mining Corp. (TSX VENTURE: GQC) (FRANKFURT: M1W) (BERLIN: M1W) ("GoldQuest" or the "Company") is pleased to report assay results from the latest seven drill holes from its Cachimbo Discovery located within the Company's 100% owned Tireo Concessions in the Dominican Republic. Mineralization at Cachimbo remains open in all directions. The Company's 50-km-long land package also hosts multiple targets areas and the multi-million-ounce gold/copper Romero Project, 22 km to the north-west, which this week received approval from the Ministry of Mines for a 75-year Exploitation License (see release of Jan 22nd, 2018).
Upvote Downvote

 
GoldQuest: DR Minister of Mines approves Exploitation Permit for the Romero Project

2018-01-22 marketwired
VANCOUVER, BC--(Marketwired - January 22, 2018) - GoldQuest Mining Corp. (TSX VENTURE: GQC) (FRANKFURT: M1W) (BERLIN: M1W) ("GoldQuest" or the "Company") is pleased to report that in a press conference today in Santo Domingo that Minister Isa Conde, the Minister of Energy and Mines ("MEM") of the Dominican Republic, has completed his review of GoldQuest's Exploitation Permit Application for the Company's 100% owned Romero Project, approved the Application, and sent it to the President of the Republic for ratification.
Upvote Downvote

12
Top 20 Gold Mining Stocks For 2018

2018-01-02 seekingalpha
Above are my Top 20 gold mining stocks for 2018. All of these companies have large resources and are highly undervalued based on their cash flow potential at higher gold prices. They are on this list primarily because of their upside potential. These are either producers or development stocks, although there is one optionality play (Goldmining Inc).
Upvote Downvote

 
GoldQuest: Receives Exploration Licenses from DR government

2017-11-17 marketwired
VANCOUVER, BC--(Marketwired - November 17, 2017) - GoldQuest Mining Corp. (TSX VENTURE: GQC) (FRANKFURT: M1W) (BERLIN: M1W) ("GoldQuest" or the "Company") is pleased to report that the Ministry of Mines and Energy of the Dominican Republic ("MEM") has granted two new Exploration Licenses to the Company. The Tocon de Pino and Hoyo Prieto Exploration Licenses are located in the centre of the Dominican Republic, with Tocon de Pino located 4 kilometres east of GoldQuest's Cachimbo discovery.
Upvote Downvote

1
Mining Stocks - Watchlist (October 30, 2017)

2017-10-31 seekingalpha
The spot prices of gold and silver have held up for the most part this year, but many mining stocks are showing weakness as we head into Q4.
Upvote Downvote

 
GoldQuest: Intersects 26.6 metres grading 4.2 g/t Gold Equivalent at Cachimbo Discovery

2017-10-26 marketwired
VANCOUVER, BC--(Marketwired - October 26, 2017) - GoldQuest Mining Corp. (TSX VENTURE: GQC) (FRANKFURT: M1W) (BERLIN: M1W) ("GoldQuest" or the "Company") is pleased to report assay results from the latest drillhole and the lower part of the previous drillhole from its Cachimbo Discovery, a Volcanogenic Massive Sulphide (VMS) deposit located within the Company's 100% owned Tireo Concessions in the Dominican Republic.
Upvote Downvote

 
Resource Sector Digest: Is The Streaming Sector Doomed? A Closer Look At Franco Nevada's Cash Problem

2017-10-24 seekingalpha
Franco Nevada is diversifying into oil and gas - but what will the other streamers do?
Upvote Downvote

 
GoldQuest: Intersects 21.0 metres grading 10.2 g/t Gold Equivalent at Cachimbo Discovery

2017-10-17 marketwired
VANCOUVER, BC--(Marketwired - October 17, 2017) - GoldQuest Mining Corp. (TSX VENTURE: GQC) (FRANKFURT: M1W) (BERLIN: M1W) ("GoldQuest" or the "Company") is pleased to report assay results from the latest 8-drill hole batch from its Cachimbo Discovery, a Volcanogenic Massive Sulphide (VMS) deposit located within the Company's 100% owned Tireo Concessions in the Dominican Republic. Cachimbo remains open in all directions.
Upvote Downvote

 
GoldQuest Intersects 11.7 metres grading 6.3 g/t gold at Cachimbo Discovery

2017-08-10 marketwired
VANCOUVER, BC--(Marketwired - August 10, 2017) - GoldQuest Mining Corp. (TSX VENTURE: GQC) (FRANKFURT: M1W) (BERLIN: M1W) ("GoldQuest" or the "Company") is pleased to report assay results from the latest 4-hole batch of drill holes from its ongoing Tireo exploration drill program. The holes are all from the recent Cachimbo Volcanogenic Massive Sulphide (VMS) Discovery. All drilling occurs within the Company's 100% owned Tireo Concessions, which hosts the multi-million-ounce Romero Project in the Dominican Republic.
Upvote Downvote

 
Yukon Territory: Undervalued And Under The Radar With Strategic Metals Ltd.

2017-08-09 seekingalpha
Strategic Metals exposes your portfolio to +100 precious metals exploration properties and interests in the Yukon.
Upvote Downvote

 
GoldQuest Intersects 12 metres grading 8.2 g/t gold equivalent in follow up hole at Cachimbo Discovery

2017-07-13 marketwired
VANCOUVER, BC--(Marketwired - July 13, 2017) - GoldQuest Mining Corp. (TSX VENTURE: GQC) (FRANKFURT: M1W) (BERLIN: M1W) ("GoldQuest" or the "Company") is pleased to report assay results from the latest 4-hole batch of drill holes from its ongoing Tireo exploration drill program. The program is focused on identifying new gold systems and defining the extents of the mineralization at the recent Cachimbo Volcanogenic Massive Sulphide (VMS) Discovery.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 38144C100